[HTML][HTML] Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy

…, C Bellezza, E Harusha, F Rossi, E Arboscello… - Clinical Microbiology …, 2020 - Elsevier
Objectives To describe clinical characteristics, management and outcome of individuals
with coronavirus disease 2019 (COVID-19); and to evaluate risk factors for all-cause in-hospital …

Serial troponin for early detection of nivolumab cardiotoxicity in advanced non‐small cell lung cancer patients

M Sarocchi, F Grossi, E Arboscello, A Bellodi… - The …, 2018 - academic.oup.com
Background Rare cases of severe myocarditis are reported during treatment with nivolumab.
Troponin, a biomarker of cardiac damage, is a key component of the diagnostic workup of …

Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: a translational 18F-FDG PET/CT observation

…, L Emionite, F Ticconi, E Arboscello… - Journal of Nuclear …, 2017 - Soc Nuclear Med
The present translational study aimed to verify whether serial 18 F-FDG PET/CT predicts
doxorubicin cardiotoxicity. Methods: Fifteen athymic mice were treated intravenously with saline …

Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion

M Breccia, P Pregno, P Spallarossa, E Arboscello… - Annals of …, 2017 - Springer
Ponatinib (Iclusig, ARIAD Pharmaceuticals-Incyte Co.) is a third-generation structure-guided
tyrosine kinase inhibitor that is approved for treatment of Philadelphia chromosome-positive …

Arterial hypertension in cancer: The elephant in the room

G Tini, M Sarocchi, G Tocci, E Arboscello… - International journal of …, 2019 - Elsevier
The great therapeutical success achieved by oncology is counterbalanced by growing evidences
of cardiovascular (CV) toxicity due to many antineoplastic treatments. Cardiac adverse …

[HTML][HTML] An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with …

M Sarocchi, M Bauckneht, E Arboscello… - Journal of Translational …, 2018 - Springer
Background Doxorubicin (DOX)-based chemotherapy for Hodgkin lymphoma (HL) yields
excellent disease-free survival, but poses a substantial risk of subsequent left ventricular (LV) …

[HTML][HTML] How to monitor cardiac complications of immune checkpoint inhibitor therapy

…, M Sarocchi, G Tini, E Arboscello… - Frontiers in …, 2020 - frontiersin.org
Immune-checkpoint inhibitors (ICIs) represent a successful paradigm in the treatment of
cancer. ICIs elicit an immune response directed against cancer cells, by targeting the so-called …

[PDF][PDF] Identification and management of immune checkpoint inhibitor–related myocarditis: use troponin wisely

…, G Tini, M Sarocchi, E Arboscello… - Journal of Clinical …, 2019 - clf1.medpagetoday.com
Background Myocarditis is an uncommon, but fearsome complication of immune checkpoint
inhibitors (ICPis) because it may result in life-threatening heart failure, cardiogenic shock, …

[HTML][HTML] Redox imbalances in ageing and metabolic alterations: implications in cancer and cardiac diseases. An overview from the working group of cardiotoxicity and …

…, C Santoro, P Ameri, P Spallarossa, E Arboscello… - Antioxidants, 2020 - mdpi.com
Metabolic syndrome (MetS) is a well established risk factor for cardiovascular (CV) diseases.
In addition, several studies indicate that MetS correlates with the increased risk of cancer in …

On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic

…, V Ricucci, D Ferone, P Barbera, E Arboscello… - Journal of Virological …, 2021 - Elsevier
Background Viral RNA amplification by real-time RT-PCR still represents the gold standard
for the detection of SARS-CoV-2, but the development of rapid, reliable and easy-to-perform …